Barcelona biotech, a spin-off of Pompeu Fabra, developing the FiCAT gene writing platform for next-generation CAR-T therapies.
Create a free EquityFlow account to see Integra Therapeutics's 1 funding round, 6 investors, 12 similar companies.
Sign up free → Sign in